"文博会是无可替代的经济文化科技交流超级平台。"韩非子在谈及参展体验时强调，文博会不仅是展示 产品、收获订单的平台，更是行业趋势的"风向标"和创意灵感的"策源地"。为表达对深圳这座奇迹之城 的热爱，该公司还带来了两款致敬深圳的限定产品——"荔枝（励志）咖啡"与"龙眼（龙耀）咖啡"。 韩非子还介绍，早前，公司就已经布局在深圳建设华南总部，目前已与深圳政府有关部门及深圳"机器 人谷"进行了对接，有望在年内落地。"期待以深圳为支点，打造辐射全球的海外市场网络，让氦豚的咖 啡机器人走向更多国家和地区。" （文章来源：深圳商报） 今年，公司以超3倍的人力物力返场：展位数增至6个，设备规模扩大至7台，同时也派出了20多人的精 英销售团队前来推介。"考虑到全球经济和关税事件影响，我们原本以为今年的海外订单会减少，最高 目标是达到去年同期水平。没想到客户咨询和意向订单迎来'井喷'。截至5月25日，深度意向客户就达 到了去年的两倍。"韩非子欣喜地说道。他介绍，展会期间，每天都有好几批客户飞往总部工厂和研发 中心考察，并快速确认合同细节，其中不少已经支付定金。 谈及产品的"爆单密码"，韩非子认为，主要得益于技术突破叠加文博会的全 ...

随着中美关税冲突缓和，公募基金调研节奏显著加快。高端制造、半导体、医疗健康三大领域成为资金聚焦的 核心赛道，百济神州- U（688235.SH）、安集科技（688019.SH）、恒而达（300946.SZ）等龙头企业获超 200 家机构扎堆调研，凸显机构对技术突破与政策红利的强烈关注。 鹏华基金闫思倩、景顺长城基金农冰立等明星基金经理现身恒而达调研现场，闫思倩、申万菱信基金付娟、华 泰柏瑞基金赵楠共同调研祥鑫科技（002965.SZ），显示出基金经理对先进制造企业的密集关注。 硬科技公司获基金经理调研 数据显示，5月以来公募基金调研呈现"量质齐升"特征。 5月以来，A股市场机构调研热度持续攀升，已有超2000家上市公司获调研。其中，公募基金调研节奏显著 加快。 券商中国记者注意到，2025年5月以来，公募基金对上市公司的调研活动呈现显著的结构性分化，高端制造、 半导体及医疗健康领域成为机构资金布局的核心方向。数据显示，工业机械、半导体设备及创新药企的调研频 次占比超六成，头部企业的技术突破与政策红利成为基金经理关注的重点方向。 从行业分布看，机构调研呈现鲜明的赛道偏好，计算机、通信和其他电子设备制造业以超过3 ...

Core Insights - Xinjiang is leveraging its abundant energy resources to explore transformation paths through industrial upgrades and technological breakthroughs, creating a new model for resource-based regions in the west of China [1][2] Group 1: Company Developments - China National Petroleum Corporation's Karamay Petrochemical Company has developed a food-grade white oil product through a seven-step refining process, which is widely used in food, pharmaceuticals, cosmetics, and vaccines [1] - The company has achieved full localization of key equipment and catalysts used in the hydrogenation process, with an annual production capacity of 200,000 tons of white oil, making it the largest production base in China [2] Group 2: Energy Infrastructure - The Karamay Petrochemical Company has also developed transformer oil that fills a domestic gap and is used in the ±1100 kV Changji-Guquan UHVDC project, which is a key national project [4] - The Changji converter station is part of a major energy transmission project that sends clean electricity across 3,293 kilometers to eastern China, with an annual transmission capacity exceeding 62 billion kilowatt-hours, equivalent to two months of electricity consumption in Anhui Province [5][7] Group 3: Regional Collaboration - The collaboration between Karamay's oil production and Changji's energy transmission represents a significant regional coordination effort, enhancing the synergy between western energy resources and eastern technological capabilities [5][7]

Core Insights - The hydrogenated nitrile butadiene rubber (HNBR) industry in China is at a critical stage of technological breakthroughs and market expansion, with a projected production of 311 tons in 2024, representing a year-on-year growth of 17.36% [1][15] - China is the second-largest consumer of HNBR globally, accounting for 20.6% of total consumption, but faces a significant demand gap of 3,982 tons due to low capacity utilization [1][15] - Key technological advancements, such as the development of rhodium-ruthenium bimetallic catalysts by Beijing University of Chemical Technology and the "Zhan's catalyst" by Zannan Technology, have broken a 30-year foreign monopoly, with some products reaching international leading levels [1][15] Industry Overview - HNBR is a highly saturated specialty elastomer produced through the hydrogenation of nitrile rubber (NBR), enhancing its properties such as heat resistance (150-180℃), oxidation resistance, ozone resistance, radiation resistance, and chemical corrosion resistance [2] - The industry has evolved through three main stages: initial development (1980-2010), technological breakthroughs and industrialization (2010-2020), and high-quality development (2021-present) [4][5][6] Industry Development History - The initial stage saw the introduction of HNBR technology in China through collaborations in the 1980s, with limited production capabilities [4] - The technological breakthrough phase from 2010 to 2020 included the establishment of the first large-scale production line by Zannan Technology, marking a significant step towards domestic production [5] - The current phase emphasizes high-quality development, with domestic production capacity expected to reach 10,000 tons per year by 2024 [6][7] Industry Chain - The HNBR industry chain includes upstream raw materials (nitrile rubber, hydrogen, catalysts), midstream production processes, and downstream applications in sectors such as automotive, aerospace, and medical [9] Current Industry Status - The industry is characterized by a low capacity utilization rate of less than 40%, despite a total capacity of 10,000 tons per year, indicating a need for improved customization and market acceptance [15] - Major players like Shandong Daon, Zhejing Zansheng, and Qilu Petrochemical dominate the market, collectively holding over 80% of the production capacity [17] Key Companies' Performance - Shandong Daon has achieved a production capacity of 3,000 tons per year and has developed proprietary HNBR preparation technology, with a revenue of 1.286 billion yuan in Q1 2025, up 6.58% year-on-year [19] - Xi'an Kaili New Materials has initiated a 3,000 tons per year HNBR project, with a revenue of 626 million yuan in Q1 2025, reflecting a 105.25% increase [21] Industry Trends - The industry is shifting towards technology-intensive and high-end applications, with significant growth in demand from the military sector and high-end manufacturing [23] - Future trends include enhanced collaboration across the industry chain, green manufacturing practices, and increased international competition as foreign companies enter the market [24][26]

Core Viewpoint - The global lithium battery market is expected to undergo structural changes in 2025, driven by the acceleration of new energy scenarios, safety standards, and technological innovations in materials and AI, pushing energy density beyond 500Wh/kg and nearing the commercialization of solid-state batteries [3]. Group 1: Event Overview - The "2025 High-tech Sodium Battery Industry Summit" will be held on June 9 at the Shangri-La Hotel in Suzhou, organized by GGII and sponsored by Zhongna Energy [2]. - The "2025 High-tech Solid-State Battery Technology and Application Summit" will take place on June 10 at the same venue, organized by GGII and sponsored by Liyuanheng [2]. Group 2: Industry Trends - The lithium battery market is facing dual challenges of "technological breakthroughs" and "ecological restructuring" due to increasing global trade barriers [3]. - The new national standard for power batteries emphasizes safety, compelling continuous upgrades in product safety [3]. Group 3: Live Broadcast Events - The live broadcast event "2025 High-tech Lithium Battery Cloud Exhibition" will occur on May 15-16, featuring 37 companies from the lithium battery and solid-state battery supply chain, focusing on technological frontiers and market trends [3]. - The first session on May 15 will discuss the full-scenario technology matrix and global service strategies, featuring companies like EVE Energy and Guoxuan High-Tech [5]. - The second session will focus on multi-dimensional innovations in scenarios, technology, and ecology, with participation from companies such as Jiatuo Intelligent and Xian Dao Intelligent [6]. - The third session will address next-generation battery manufacturing upgrades, emphasizing efficiency and energy-saving solutions [8]. Group 4: Roundtable Discussions - The first roundtable on May 16 will explore the material revolution and performance breakthroughs in power batteries, discussing achieving 500Wh/kg energy density and the challenges of solid-state battery materials [10]. - The second roundtable will analyze the globalization strategies of material companies, addressing challenges in breaking into the European and American markets and the evolution of the market post-2025 [11].

Core Insights - The forum organized by Beijing Antai Technology Co., Ltd. focused on the development of the non-ferrous metal industry and showcased academic insights [1][3] Group 1: Industry Challenges and Opportunities - The non-ferrous metal industry is facing multiple opportunities and challenges, including green transformation, technological breakthroughs, and global industrial chain restructuring [3] - The electrolytic copper foil industry has shifted from a shortage to a severe oversupply due to chaotic capacity expansion, leading to a significant decline in processing fees and widening losses for companies [4] - Despite a slight recovery in processing fees in Q1 2025, the industry remains in a struggling phase, with long-term oversupply expected as many paused projects may restart when demand increases [4] Group 2: Market Analysis and Strategic Recommendations - The report on the aluminum industry highlighted the complexities of trade barriers, particularly due to the escalation of the trade war by the U.S., which negatively impacts the global aluminum supply chain [5] - China is expected to maintain a dominant position in the global aluminum supply chain despite external challenges, with companies advised to adapt to new changes, enhance product value, and diversify global supply chains [5] - Various young analysts presented insights on the metal industry chain, including gold concentrate, zinc, nickel, and antimony, providing recommendations for future strategies [5]

然而，事情并没有像美国预想的那样发展。中国进行反制之后，美国的超市物价开始飞涨，民众也是怨声载道。特朗 普原本还想扮演"俄乌调停人"的角色，可是在5月2日突然就改口说让俄乌自己去谈，然后转头就把尼米兹号航母开到 了中国附近海域。这时间线看起来太巧合了，2月关税战开始，到了5月就甩掉乌克兰这个包袱，想要腾出精力全力来 对付中国。 说中国"偷技术"这种说法根本站不住脚。就拿华为来说，华为的5G专利在全球都是排名第一的，还有大疆无人机，它 在美国市场的占有率能达到80%。而且美国越是打压，中国的技术突破反而越快。所谓中国商品"低价倾销"美国，这 更是一个笑话。中国商品在欧美即便涨价20%，美国人依旧会抢购。至于汇率问题，美国的说法就更荒唐了。2023年 美联储加息七次，美元的波动给全球都带来了不良影响，现在却反过来咬人民币"操纵汇率"。 特朗普上台之后不久就开始针对中国采取行动了。在5月5日之前，美国在关税方面层层加码，关税从最初的10%一路 飙升到145%，这一举措太狠了。面对美国的这种做法，中国也毫不示弱，当即以同等力度进行回击。 早在2月1日的时候，美国就开始对中国加征10%的关税，这使得平均税率提高到了29 ...

作者丨Eyan 本期推荐阅读5分钟 本期导读： 技术突破和政策红利正共同推动外资LP对中国市场的"再认识"。 在全球经济格局深刻调整的当下，"东升西落"不再仅是中国内部的战略共识，而是逐渐成为全球资 本市场的现实写照。美国对中国发起的关税战不仅未能遏制中国的发展，反而在全球范围内引发了 对美国经济政策的不信任。与此同时，美债收益率的飙升和美股高估值的持续，使得美元资产的信 用风险日益凸显。在这样的背景下，中国以其稳健的经济增长和日益完善的投资环境，成为全球资 本寻求避风港的新选择。外资LP们开始悄然布局中国市场，寻找新的增长点和投资机会。这一趋 势不仅体现了全球资本对中国市场的重新评估，也标志着中国在全球资本流动中的角色正在发生深 刻变化。 外资重新"认识"中国 今年4月以来美国对全球，尤其是中国，发起的关税战引发了广泛的国际抵制。曾被视为"避风 港"的美元资产，如今正面临信任危机。美债收益率飙升、美股高估值泡沫、以及对华关税战的持 续升级，使得投资者开始重新审视美国资产的安全性。与此同时，中国市场以其稳定的政策环境和 科技创新能力，逐渐成为全球资本的避风港。 美国国债市场一直被视为全球最安全的投资标的。然而 ...

Revenue and Profit Performance - In Q1 2025, 265 listed companies on the Beijing Stock Exchange achieved total operating revenue of CNY 40.358 billion, a year-on-year increase of 5.81%[16] - The net profit attributable to shareholders was CNY 2.612 billion, down 7.50% year-on-year[16] - Among the companies, 162 reported revenue growth, with 78 companies exceeding 20% growth and 18 companies surpassing 50% growth[16] Market Trends and Index Performance - As of April 29, 2025, the North Exchange 50 Index rose by 1.70% in April, with a maximum increase of 8.38% during the period[17] - Year-to-date, the North Exchange 50 Index has increased by 24.57%, with a peak increase of 39.52%[17] - A total of 131 stocks rose, while 134 stocks fell, with no stocks remaining flat during April[17] Valuation Metrics - The average PE (TTM) for the North Exchange 50 Index was 58.99 times, with a median of 59.76 times as of April 29, 2025[23] - The ChiNext Index had an average PE of 30.10 times, while the Sci-Tech Innovation Board had an average PE of 79.68 times[23] Trading Activity - The total trading volume for the North Exchange in April 2025 was CNY 586.958 billion, with a volume of 28.832 billion shares traded[24] - The average margin financing and securities lending balance for March 2025 was CNY 5.277 billion, a decrease of 2.95% month-on-month[26] Investment Recommendations - Focus on high-growth new productivity sectors and competitive niche leaders[16] - Emphasize innovation-driven sectors such as semiconductors, military, AI, and satellite internet for domestic substitution and technological breakthroughs[16] - Anticipate benefits for consumer-related companies as policies aim to boost domestic demand and consumption[16] Risks - Potential risks include slower-than-expected policy implementation affecting market stability[38] - Short-term stock price surges may lead to overheating market sentiment, prompting irrational investment behavior[38]

Group 1: Company Overview and Market Position - The company is a leading player in the nitroimidazole antibiotic sector, particularly known for its metronidazole raw materials, with the longest industrial chain and the most product varieties globally [2][3] - The main products include metronidazole and its derivatives, with the largest global production capacity and market share, recognized for product quality and cost competitiveness [2][3] Group 2: Performance and Challenges - In 2024, the company faced a significant decline in performance, primarily due to the lithium hexafluorophosphate and metronidazole businesses, with a notable drop in sales prices despite increased sales volume [3][4] - The lithium battery materials sector experienced intensified competition, leading to lower sales prices for lithium hexafluorophosphate, which adversely affected profitability [3][4] - The decline in metronidazole profitability was attributed to increased competition and a decrease in product unit prices, which fell more than the reduction in unit costs [3][4] Group 3: Strategic Responses - The company has implemented a multi-faceted strategy to address current challenges, including cost optimization through production line upgrades and supply chain management [3][4] - Increased investment in research and development to accelerate product technology upgrades and new product development is a key focus [3][4] - Efforts to expand into high-margin product markets are underway to enhance overall profitability [3][4] Group 4: Financial Health and Future Outlook - The company maintains a healthy cash flow and robust financial structure, ensuring sufficient reserves for future operations and investment plans [4] - There are no current risks of delisting as per the Shenzhen Stock Exchange regulations [4] - The company has received approvals for new drug applications, including for sitagliptin phosphate and celecoxib, indicating ongoing product development [4]